M&A-led growth, $1B+ backlog and data center demand—plus margin, cash flow and leverage risks. Click for more on FPS stock.

Initial public offering listings rebounded last year, though their performance—and a government shutdown—held back some ...

Rs 1.75 lakh crore raised, but it also killed the "quick flip." With average listing gains crashing from 30% to just 9%, retail investors are fleeing. Yet, a massive 326% return secret is hidden in ...

Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for ...

Medline MDLN, a private equity-backed medical-surgical products provider, went public Tuesday in the largest IPO of the year, drawing strong investor demand. The Northfield, Il.-based company raised ...

Market watchers flag over Rs 2.65 lakh crore pipeline, strong domestic investor support and regulatory tweaks, while warning that valuations, global cues and listing gains remain key risks ...

After euphoric listings and sharp corrections, can India’s IPO market recalibrate valuations, protect retail capital, and ...

Even as concerns are being raised from various corners about the fact that IPOs are now becoming a tool for OFS and providing exit to existing investors and dilution to promoters, market experts say ...

What's more, the juggernaut shows little sign of slowing. Companies have filed draft papers for IPOs worth Rs 3.5 trillion, excluding mega issues from Reliance Jio, Flipkart, and the National Stock ...